HB Wealth Management »

Candel Therapeutics shares owned by HB Wealth Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by HB Wealth Management from 13F filings

Historical chart of HB Wealth Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by HB Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by HB Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $393k 57k 6.93

More positions owned by HB Wealth Management

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Home Depot (HD)
Apple (AAPL)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)

View all positions for HB Wealth Management

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics